会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • COMMUNICATION INTERFACE DEVICE
    • 通信接口设备
    • US20130287075A1
    • 2013-10-31
    • US13977164
    • 2011-01-27
    • Satoshi EndoYoshiaki KoizumiToshiyasu HigumaTakuya Mukai
    • Satoshi EndoYoshiaki KoizumiToshiyasu HigumaTakuya Mukai
    • H04L25/02
    • H04L25/0262H04L12/6418H04L25/05H04L25/491
    • A sampler samples a receive signal received via a dedicated communication line. A data transfer rate adjuster measures a data transfer rate based on a number of start bit samples contained in the receive signal. A bit determiner makes a bit determination regarding the receive signal at the data transfer rate measured by the data transfer rate adjuster, to thereby acquire serial data contained in the receive signal. A transmitter sends, via the dedicated communication line, a transmit signal containing serial data sent by an MPU. An MPU communicator outputs to the transmitter the serial data sent by the MPU, and outputs to the MPU the serial data acquired by the bit determiner. The data transfer rate adjuster adjusts, when the transmitter sends the transmit signal multiple times at different data transfer rates, the data transfer rate based on the receive status of respective response signals thereto.
    • 采样器对通过专用通信线路接收到的接收信号进行采样。 数据传送速率调整器基于包含在接收信号中的起始比特数目的数量来测量数据传送速率。 位确定器对由数据传输速率调整器测量的数据传输速率的接收信号进行位确定,从而获取包含在接收信号中的串行数据。 发送器通过专用通信线路发送包含由MPU发送的串行数据的发送信号。 MPU通信器向MPU发送由MPU发送的串行数据,并向MPU输出由位确定器获取的串行数据。 当发送器以不同的数据传输速率多次发送发送信号时,数据传输速率调整器根据各个响应信号的接收状态来调整数据传输速率。
    • 7. 发明授权
    • Pentapeptide with specific conformation, its production and use
    • 具有特定构象的五肽,其生产和使用
    • US06610655B2
    • 2003-08-26
    • US09999432
    • 2001-11-15
    • Mitsuhiro WakimasuHiroshi InookaSatoshi EndoTakashi Kikuchi
    • Mitsuhiro WakimasuHiroshi InookaSatoshi EndoTakashi Kikuchi
    • C07K102
    • C07K7/64A61K38/00
    • Cyclic pentapeptides are disclosed having the following formula (I)-Cyclo(-A1-A2-A3-A4-A5-)-wherein A1, A2, A3, A4 and A5 are amino acid residues. The pentapeptide has amino acid residues in positions 1-2-3 to form a &ggr;-turn, and amino acid residues in positions 3-4-5-1 to form a &bgr;-turn in combination with the &ggr;-turn. D-&agr;-amino acid residues are selected for A1, A3, and A5 and L-&agr;-amino acid residues are selected for A2 and A4. Compounds having &ggr;-turns and &bgr;-turns can be synthesized, regardless of the kinds of amino acid residues, and it is possible to synthesize compounds in which desired amino acid residues are introduced into sites of &bgr;-turn and &ggr;-turn based on their importance from the viewpoint of biological activity. The present invention is therefore available for design of compounds having biological activity.
    • 公开了具有下式(I)-Cyclo(-A1-A2-A3-A4-A5-))的环五肽 - 其中A1,A2,A3,A4和A5是氨基酸残基。 五肽在1-2-3位具有氨基酸残基以形成γ-转角,并且3-4-5-1位置的氨基酸残基与γ转弯结合形成β-转角。 选择A1,A3和A5的D-α-氨基酸残基,A2和A4选择L-α-氨基酸残基。 可以合成具有γ-匝数和β-匝数的化合物,而不考虑氨基酸残基的种类,并且可以合成其中所需氨基酸残基被引入β-匝和γ-匝转位点的化合物 从生物活动的角度来看重要。 因此,本发明可用于设计具有生物活性的化合物。
    • 8. 发明授权
    • Pentapeptide with specific conformation, its production and use
    • 具有特定构象的五肽,其生产和使用
    • US5965526A
    • 1999-10-12
    • US551251
    • 1995-10-31
    • Mitsuhiro WakimasuHiroshi InookaSatoshi EndoTakashi Kikuchi
    • Mitsuhiro WakimasuHiroshi InookaSatoshi EndoTakashi Kikuchi
    • A61K38/00C07K1/00C07K7/64A61K38/12
    • C07K7/64C07K1/00A61K38/00
    • Cyclic pentapeptides are disclosed having the following formula (I) --Cyclo(-A.sub.1 -A.sub.2 -A.sub.3 -A.sub.4 -A.sub.5 -)-- wherein A.sub.1, A.sub.2, A.sub.3, A.sub.4 and A.sub.5, are amino acid residues. The pentapeptide has amino acid residues in positions 1-2-3 to form a .gamma.-turn, and amino acid residues in positions 3-4-5-1 to form a .beta.-turn in combination with the .gamma.-turn. D-.alpha.-amino acid residues are selected for A.sub.1, A.sub.3, and A.sub.5 and L-.alpha.-amino acid residues are selected for A.sub.2 and A.sub.4. Compounds having .gamma.-turns and .beta.-turns can be synthesized, regardless of the kinds of amino acid residues, and it is possible to synthesize compounds in which desired amino acid residues are introduced into sites of .beta.-turn and .gamma.-turn based on their importance from the viewpoint of biological activity. The present invention is therefore available for design of compounds having biological activity.
    • 公开了具有下式(I)-Cyclo(-A1-A2-A3-A4-A5-))的环五肽,其中A1,A2,A3,A4和A5是氨基酸残基。 五肽在1-2-3位具有氨基酸残基以形成γ转角,并且3-4-5-1位置的氨基酸残基与γ转角组合形成β转角。 A1,A3和A5选择D-α-氨基酸残基,A2和A4选择L-氨基酸残基。 可以合成具有γ-转角和β-转角的化合物,而不管氨基酸残基的种类如何,并且可以合成其中所需氨基酸残基被引入β-转角和γ转角的位点的化合物,基于它们 从生物活动的角度来看重要。 因此,本发明可用于设计具有生物活性的化合物。
    • 9. 发明授权
    • Liquid crystal display device with unequal sized dummy sub-electrodes
having a specific relationship
    • 具有不同大小的虚拟子电极的液晶显示装置具有特定的关系
    • US5838411A
    • 1998-11-17
    • US988234
    • 1997-12-10
    • Kouji HayakawaSatoshi EndoHisashi YoshidaNoboru HoshinoMasayoshi Fujieda
    • Kouji HayakawaSatoshi EndoHisashi YoshidaNoboru HoshinoMasayoshi Fujieda
    • G02F1/133G02F1/1333G02F1/1335G02F1/1343
    • G02F1/134336G02F1/133512G02F2001/133388
    • A liquid crystal display device includes a liquid crystal display panel. The liquid crystal display panel includes a first transparent substrate having color filters arranged in a predetermined order, a patterned light blocking film formed between the color filters and first transparent electrodes formed on the color filters; a second transparent substrate having second transparent electrodes arranged to intersect the first transparent electrodes; a liquid crystal layer sandwiched between the first and second transparent substrates with the first and second transparent electrodes opposing each other and spacers dispersed between the first and second transparent substrates. The color filters and the light blocking film extend into a marginal area outside an area optically switchable upon application of an electric field on the liquid crystal display panel in substantially the same geometric pattern as within the optically switchable area. A plurality of dummy electrodes can also be formed in the marginal area on at least one of the first and second substrates, so as to oppose the transparent electrodes on the opposite substrate. The extension of the color filters and the light blocking film into a marginal area and the disposition of the dummy electrodes in the marginal area can be applied in one liquid crystal display panel, singly or in combination.
    • 液晶显示装置包括液晶显示面板。 液晶显示面板包括具有以预定顺序布置的滤色器的第一透明基板,形成在滤色器和形成在滤色器上的第一透明电极之间的图案遮光膜; 第二透明基板,具有布置成与第一透明电极相交的第二透明电极; 夹在第一和第二透明基板之间的液晶层,其中第一和第二透明电极彼此相对,分隔在第一和第二透明基板之间。 滤色器和遮光膜延伸到在可与光可切换区域基本相同的几何图案中的在液晶显示面板上施加电场之后可光学切换的区域中的边缘区域。 多个虚拟电极也可以形成在第一和第二基板中的至少一个上的边缘区域中,以与相对基板上的透明电极相对。 将滤色器和遮光膜延伸到边缘区域中,并且虚拟电极在边缘区域中的布置可以单独地或组合地应用于一个液晶显示面板。